ReviewOncology reports2025
O‑GlcNAcylation as an emerging molecular target for cholangiocarcinoma therapy (Review).
Purin Charoensuksai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewOncology reports2025
Purin Charoensuksai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.